Before choosing a Joi+Blokes plan, ask for two things together: the exact medicine being considered and the written financial terms attached to it. Its public pages describe compounded semaglutide, compounded tirzepatide, compounded liraglutide and a Zepbound program, but these are not interchangeable purchases. Some advertised prices include medication; the Zepbound service price does not. The practical question is therefore not simply whether the monthly figure looks affordable, but what prescription, services, payment schedule and responsibilities that figure actually buys.
This documentary review examines public documentation consulted October 19, 2026, with an emphasis on questions patients can resolve before paying. Joi+Blokes also markets hormone and wellness services, but this review centers on weight-management care. Its pages describe consultations, coaching, pharmacy fulfillment and payment options in useful detail. They also leave consequential uncertainty about cancellation, refunds and the relationship between quarterly billing and general subscription terms. A useful starting point is our guide to what a GLP-1 program should explain before enrollment, applied here to the provider’s specific offerings rather than a generic checklist.
At a glance
- Platform role
- Joi+Blokes says it connects patients with third-party medical providers and does not itself practice medicine or provide healthcare services.Sources: [7]
- Compounded injection prices
- Compounded semaglutide is advertised at $179/month, first month $99; compounded tirzepatide at $249/month, first month $149. Both are billed quarterly and include medication and support.Sources: [6]
- Zepbound service fee
- The Zepbound program advertises $99/month, collected as $297 for three months, excluding medication. Listed Lilly Direct vials require a separate cash purchase and are not insurance-eligible through that channel.Sources: [3]
- Conflicting cancellation language
- Product marketing says patients can cancel anytime, while general subscription terms specify a three-month minimum and cancellation thirty days before the next monthly processing date after that commitment.
Ask which purchase you are actually making
Joi+Blokes presents more than one route into weight-management care. Its compounded semaglutide and tirzepatide offerings are described as subcutaneous injections, and its liraglutide page likewise describes a compounded formulation injected under the skin. Separately, the Zepbound page offers a service program surrounding a branded tirzepatide injection. Before comparing prices, ask the clinician to identify the intended product, whether it is compounded, its presentation and the dispensing pharmacy. Our guide to identifying the medicine behind an offer explains why those details belong ahead of the price comparison.
The distinction matters beyond branding. FDA approval concerns a specific drug product, not Joi+Blokes as a platform or the pharmacies it lists. FDA says compounded preparations are not approved and do not undergo its premarket review for safety, effectiveness and quality; that fact alone does not prove clinical inequivalence. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Ask why a particular preparation is being proposed rather than treating the website’s menu as a recommendation for you.
| Offering | Published price and structure | Question to resolve |
|---|---|---|
| Compounded subcutaneous semaglutide | $179/month; first month $99; billed quarterly; medication, dosing support, consultations and coaching included | What exact amount is collected at checkout and at renewal? |
| Compounded subcutaneous tirzepatide | $249/month; first month $149; billed quarterly; medication, dosing support, consultations and coaching included | Which formulation and pharmacy will fulfill the prescription? |
| Compounded subcutaneous liraglutide | $299/month; virtual visits, personalized coaching, lab access and continuous support advertised | What does the charge include, and what does lab access cost? |
| Zepbound service program | $99/month, charged as $297 for three months; medication excluded | What separate medication purchase will be required? |
| Zepbound vials through Lilly Direct | $349/month for 2.5 mg; $499 for 5 mg; $599 for 7.5 mg; $699 for 10 mg; cash only, no insurance coverage for these vials; prices subject to change | Which presentation is prescribed, and what is its current cash price? |
Separate the advertised month from the actual charge
The compounded plans use monthly price labels while specifying quarterly billing. Semaglutide is advertised at $179 per month with the first month at $99; tirzepatide at $249 per month with the first month at $149. Both include medication, dosing support, clinician consultations and health coaching. The consulted documentation does not specify the exact initial quarterly collection after applying the introductory discount. Ask for that dollar amount, the date of the next charge and the subsequent quarterly amount in writing. A monthly label alone is not a monthly payment arrangement.
The $299-per-month liraglutide program lists virtual provider visits, personalized coaching, lab access and continuous support, but that description does not settle every possible charge. Zepbound is clearer about one major exclusion: its $297 three-month service payment does not purchase medication. The separately listed vial prices vary by presentation, are subject to change and apply to the documented cash-only Lilly Direct channel. Ask for a checkout summary that separates services, medicine and testing. The questions in our price checklist beyond the monthly figure are particularly relevant to these different purchasing structures.
Resolve the exit terms before entering
The most consequential documentation gap concerns leaving the program. The compounded page advertises “No membership fees” and says patients can adjust or cancel anytime. General subscription terms, however, establish a minimum of three consecutive months and automatic charges as described for the purchased product or service. Those terms allow cancellation thirty days before the next monthly processing date after the initial commitment ends. The documentation does not explain how that monthly processing reference works alongside quarterly billing. Ask which provision governs your named plan and the earliest date cancellation can stop another charge.
Refund language also varies by offering. A prescription-product page promises an immediate refund when a clinician determines prescribing is inappropriate. The policy for insurance-supported GLP-1 subscriptions instead says paid subscription fees cannot be refunded, including when a person is not a candidate or approved. Prescription products cannot be returned, and diagnostic lab purchases and lab subscriptions are final and nonrefundable. These are distinct boundaries: cancellation does not establish a refund right, and an advertised immediate refund does not establish when a bank will post it. Obtain a written explanation addressing the specific fee before payment.
Identify who evaluates you and who remains responsible
Joi+Blokes identifies itself as the website’s owner and operator, but its terms say it does not practice medicine or directly provide healthcare. Instead, it connects users with third-party medical providers. The advertised process begins with a health-history form and discussion with a licensed clinician, followed by partner-provider review of whether a prescription is appropriate. Consultations may be synchronous or asynchronous, and informed consent is required before telemedicine services. Ask for the clinical organization’s legal name and the treating professional’s name and credential, not simply the platform’s customer-service contact.
The website lists Melissa Loseke, DO, as medical director and Lauren Dulay, NP, as director of clinical operations and lead clinician. Those are company-reported roles, not independent verification of who will treat an individual patient. Its terms also explain that a provider may determine an issue requires an in-person visit or services unavailable through the platform, ending further treatment there for that issue. Ask how such a decision is communicated, who arranges the next step and how charges are handled. The pages do not identify every independent clinical group or establish a guaranteed prescription.
Confirm state availability and the purpose of any testing
The terms restrict services to people who have reached the age of majority where they live. Joi+Blokes says it treats patients and ships medication only within the United States, but that is not confirmation of coverage in every state. The compounded page specifically says semaglutide is unavailable in some states. It also says concentration and additional ingredients, such as B12, glycine or L-carnitine, depend on individual clinical needs. Ask whether the specific proposed formulation is available at your location; a general statement about U.S. service does not answer that question.
Both the compounded and Zepbound pages say labs are not required. Zepbound nevertheless offers optional Complete Hormone, Advanced and Comprehensive panels, while program descriptions refer to lab access. A shared testing-arrangement question does not establish a mandatory blood draw or included testing. Ask what a proposed panel is intended to inform, whether collection and interpretation are included, and what you would owe before ordering. The website advertises different diagnostic pricing in New York and New Jersey. Its new-customer LABS65 promotion advertises 65% off diagnostic labs, but that banner alone does not establish your final charge.
Trace the prescription through the pharmacy and delivery
The terms list Strive Pharmacy, Pharmacy Hub, Tailor Made Compounding Pharmacy, Cadre Labs LLC, Empower Pharmacy, LillyDirect Self Pay Pharmacy Solutions doing business as GiftHealth, and Partell Pharmacy as partners. That list does not identify the pharmacy assigned to your order or establish that every listed business compounds every product. If you choose another pharmacy, the terms say the prescription can be sent there, but you must obtain the medication and pay that pharmacy directly. Ask how using that option affects a plan whose advertised price already includes medication, rather than assuming the financial arrangement transfers unchanged.
For Zepbound, the page says approved patients receive a Lilly Direct text to complete a separate purchase and advertises receipt within 72 hours after approval. That is a provider delivery claim, not a promised clinical-review turnaround. General preparation and delivery timelines for compounded products and liraglutide, cold-chain arrangements and replacement policies remain unspecified. Terms also warn that containers may not be child-resistant. Ask for the dispensing pharmacy’s contact details and a delivery-problem procedure before shipment. FDA advises not using an injectable GLP-1 that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy.
Turn unlimited support into a concrete follow-up plan
The compounded programs advertise unlimited health-coach visits, clinician access and support, nutrition and lifestyle guidance, unlimited messaging and a community. Those are meaningful service descriptions, but the type of professional matters. Joi+Blokes explicitly says coaches are not doctors and cannot prescribe, diagnose or give specific medical advice. Ask which messages go to a coach, which reach a prescribing clinician and how a medication concern is escalated. The terms warn that communication may not occur in real time, so unlimited messaging should not be read as immediate clinical availability.
The public documentation does not establish a routine review schedule, prescription-renewal frequency or response-time commitment. Ask whether follow-up is scheduled automatically and how you contact the clinician between appointments; our guide to questions about support after the first prescription can help organize that conversation. NIDDK describes follow-up as attention to treatment response and tolerability, not simply continued payment. It also advises discussing other medicines, supplements, allergies and pregnancy plans with the clinician. FDA reports of compounded-medication measurement errors reinforce the importance of obtaining clear instructions from the prescriber or pharmacist rather than calculating from a review.
Keep insurance help, payment eligibility and supplements separate
Joi+Blokes says it assists with prior authorizations and prescription submissions but does not bill insurers directly. Its general coverage discussion mentions Ozempic, Wegovy, Zepbound and Mounjaro as potentially eligible, without guaranteeing coverage. That broad statement does not override the Zepbound page’s specific restriction: the listed Lilly Direct vials are cash-only and not eligible for insurance coverage through that offering. Ask the program and health plan about the exact product and pharmacy channel. Flex-based HSA/FSA payment is also conditional on verification, eligible amounts and any required letter approval; a remaining balance can require another payment method.
Keep the separately marketed GLP-1 Assist supplement out of the prescription comparison. Its plans advertise $74 for one month, $396 for six months and $708 for twelve months, all with free shipping. The six-month option also displays $65 per month, which does not reconcile with the stated package total; the annual option displays $59 per month. These are supplement offers, not evidence that a prescription medicine is included. If considering one, ask about the total charge, subscription terms and the inconsistent six-month figures, and discuss the supplement with your clinician rather than assuming it belongs in the medication plan.
Questions & answers
Can I pay for the compounded plan one month at a time?
The advertised semaglutide and tirzepatide prices are expressed monthly, but the page specifies quarterly billing. It does not establish an optional monthly-payment arrangement or the exact initial quarterly collection with the first-month discount. Request the checkout amount, renewal amount and applicable commitment before authorizing payment.
Does the $99 Zepbound program include the drug?
No. The advertised $99 monthly service rate is collected as $297 for three months and excludes medication. The page lists separate monthly vial prices from $349 to $699 for specified presentations. Those purchases go through Lilly Direct, are cash-only and are not insurance-eligible through that vial offering; prices may change.
Will I receive a refund if I am not prescribed medication?
The documents do not give one consistent answer across programs. A prescription page promises an immediate refund if prescribing is inappropriate, while the insurance-supported GLP-1 policy makes paid subscription fees nonrefundable even without candidacy or approval. Ask which policy applies to your exact purchase and which charges it covers.
Are blood tests mandatory or free?
The compounded and Zepbound pages say labs are not required. Optional panels are offered, and some program descriptions include lab access, but access does not establish free testing, collection or interpretation. Confirm an itemized price before ordering because diagnostic lab sales and lab subscriptions are described as final and nonrefundable.
Who can answer a medication question after enrollment?
The programs advertise clinician access alongside unlimited coaching and messaging. Coaches cannot prescribe, diagnose or provide specific medical advice, and the terms say communications may not be real-time. Request the route to the prescribing clinician and dispensing pharmacist, plus expected response times, rather than relying on the word unlimited.
Can I use a pharmacy outside the listed partners?
The terms allow a prescription to be sent to a selected outside pharmacy. You then become responsible for obtaining the medication and paying that pharmacy directly. Before choosing this route, ask whether the program fee changes, especially for compounded plans whose advertised price includes medication, and confirm the pharmacy can fulfill the prescription.
Our assessment
Joi+Blokes provides a comparatively detailed description of its medication menu, coaching services, partner-pharmacy structure and several payment arrangements. Patients can identify meaningful differences between medication-inclusive compounded plans and the separate service-and-drug purchases required for Zepbound. The strongest reason to pause before checkout is not an absence of offerings, but unresolved financial boundaries: quarterly billing lacks an exact introductory collection amount, cancellation language conflicts, and refund eligibility differs across documents. A practical next step is to request one written summary naming the product, clinician organization, pharmacy, first charge, renewal date, cancellation deadline and no-prescription refund treatment. That clarification would make the offer easier to evaluate without treating marketing language as either a clinical recommendation or a complete contract.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Joi+Blokes — shop/women/weight loss/zepbound ↗
- Joi+Blokes — official website ↗
- Joi+Blokes — shop/women/supplements/glp 1 assist ↗
- Joi+Blokes — glp 1 ↗
- Joi+Blokes — terms ↗
- Joi+Blokes — shop/women/weight loss/liraglutide ↗
- Joi+Blokes — refunds and returns ↗